Klein Nikolas, Sacher Julia, Geiss-Granadia Thomas, Mossaheb Nilufar, Attarbaschi Trawat, Lanzenberger Rupert, Spindelegger Christoph, Holik Alexander, Asenbaum Susanne, Dudczak Robert, Tauscher Johannes, Kasper Siegfried
Department of General Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Psychopharmacology (Berl). 2007 Apr;191(2):333-9. doi: 10.1007/s00213-006-0666-y. Epub 2007 Jan 19.
Previous studies have investigated the occupancy of the serotonin reuptake transporter (SERT) after clinical doses of citalopram and other selective serotonin reuptake inhibitors. In the present study, the occupancies of SERT after multiple doses of escitalopram and citalopram were compared using the radioligand [(123)I]ADAM and single photon emission computed tomography (SPECT).
Fifteen healthy subjects received escitalopram 10 mg/day (n = 6) or citalopram 20 mg/day (n = 9) for a total of 10 days. SERT occupancies in midbrain were determined with SPECT and [(123)I]ADAM at three different time points: at baseline (no medication) and at 6 and 54 h after last drug intake.
At 6 h after the last dose, mean SERT occupancies were 81.5 +/- 5.4% (mean+/-SD) for escitalopram and 64.0 +/- 12.7% for citalopram (p < 0.01). At 54 h after the last dose, mean SERT occupancies were 63.3 +/- 12.1% for escitalopram and 49.0 +/- 11.7% for citalopram (p < 0.05). The plasma concentrations of the S-enantiomer were of the same magnitude in both substances. For both drugs, the elimination rate of the S-enantiomer in plasma was markedly higher than the occupancy decline rate in the midbrain.
The significantly higher occupancy of SERT after multiple doses of escitalopram compared to citalopram indicates an increased inhibition of SERT by escitalopram. The results can also be explained by an attenuating effect of R-citalopram on the occupancy of S-citalopram at the SERT.
既往研究已对临床剂量的西酞普兰及其他选择性5-羟色胺再摄取抑制剂(SSRI)后5-羟色胺再摄取转运体(SERT)的占有率进行了研究。在本研究中,使用放射性配体[(123)I]ADAM和单光子发射计算机断层扫描(SPECT)比较了多次服用艾司西酞普兰和西酞普兰后SERT的占有率。
15名健康受试者接受艾司西酞普兰10mg/天(n = 6)或西酞普兰20mg/天(n = 9),共10天。在三个不同时间点用SPECT和[(123)I]ADAM测定中脑的SERT占有率:基线时(未用药)以及最后一次服药后6小时和54小时。
最后一剂后6小时,艾司西酞普兰的平均SERT占有率为81.5±5.4%(平均值±标准差),西酞普兰为64.0±12.7%(p<0.01)。最后一剂后54小时,艾司西酞普兰的平均SERT占有率为63.3±12.1%,西酞普兰为49.0±11.7%(p<0.05)。两种药物中S-对映体的血浆浓度相当。对于两种药物,血浆中S-对映体消除率明显高于中脑占有率下降率。
与西酞普兰相比,多次服用艾司西酞普兰后SERT占有率显著更高,表明艾司西酞普兰对SERT的抑制作用增强。结果也可以用R-西酞普兰对S-西酞普兰在SERT上占有率的减弱作用来解释。